Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients

Diagnostic Microbiology and Infectious Disease

Volumn 85, Issue 1, 2016, Pages 116-120

  Abidi, M Z ^a   Ledeboer, N ^a   Banerjee, A ^a   Hari, P ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bacteremia; Neutropenia; Rothia mucilaginosa

Indexed keywords

CARBAPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; CHARLSON COMORBIDITY INDEX; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; INCIDENCE; INTRAVASCULAR CATHETER; KIDNEY DISEASE; LEUKEMIA; LIVER DISEASE; MALE; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; ROTHIA BACTEREMIA; SURVIVAL RATE; SURVIVAL TIME; ADVERSE EFFECTS; COMORBIDITY; COMPLICATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; MICROCOCCACEAE; MIDDLE AGED; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMORBIDITY; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; MICROCOCCACEAE; MIDDLE AGED; MORBIDITY; MORTALITY; NEUTROPENIA; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 84959066272     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.01.005     Document Type: Article

References (22)

1. Bruminhent J., Tokarczyk M.J., Jungkind D., DeSimone J.A. Rothia mucilaginosa prosthetic device infections: a case of prosthetic valve endocarditis. J Clin Microbiol 2013, 51(5):1629-1632.
2. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
3. Chavan R.S., Pannaraj P.S., Luna R.A., Szabo S., Adesina A., Versalovic J., et al. Significant morbidity and mortality attributable to rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. Pediatr Hematol Oncol 2013, 30(5):445-454.
4. Cho E.J., Sung H., Park S.J., Kim M.N., Lee S.O. Rothia mucilaginosa pneumonia diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient. Ann Lab Med 2013, 33(2):145-149.
5. Chowdhary M., Farooqi B., Ponce Terashima R. Rothia dentocariosa: a rare cause of left-sided endocarditis in an intravenous drug user. Am J Med Sci 2015, 350(3):239-240.
6. Crowe A., Ding N.S., Yong E., Sheorey H., Waters M.J., Daffy J. Rothia aeria mitral valve endocarditis complicated by multiple mycotic aneurysms: laboratory identification expedited using MALDI-TOF MS. Infection 2014, 42(2):419-423.
7. Fanourgiakis P., Georgala A., Vekemans M., Daneau D., Heymans C., Aoun M. Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute. Clin Microbiol Infect 2003, 9(10):1068-1072.
8. Goldman M., Chaudhary U.B., Greist A., Fausel C.A. Central nervous system infections due to Stomatococcus mucilaginosus in immunocompromised hosts. Clin Infect Dis 1998, 27(5):1241-1246.
9. Granlund M., Linderholm M., Norgren M., Olofsson C., Wahlin A., Holm S.E. Stomatococcus mucilaginosus septicemia in leukemic patients. Clin Microbiol Infect 1996, 2(3):179-185.
10. Kim U.J., Won E.J., Kim J.E., Jang M.O., Kang S.J., Jang H.C., et al. Rothia aeria infective endocarditis: a first case in Korea and literature review. Ann Lab Med 2014, 34(4):317-320.
11. Korsholm T.L., Haahr V., Prag J. Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus. Scand J Infect Dis 2007, 39(10):913-917.
12. Lee A.B., Harker-Murray P., Ferrieri P., Schleiss M.R., Tolar J. Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2008, 50(3):673-676.
13. McWhinney P.H., Kibbler C.C., Gillespie S.H., Patel S., Morrison D., Hoffbrand A.V., et al. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis 1992, 14(3):641-646.
14. Nicodemo A.C., Goncalves L.G., Odongo F.C., Martino M.D., Sampaio J.L. Rothia aeria endocarditis in a patient with a bicuspid aortic valve: case report. Braz J Infect Dis 2014, 18(5):561-564.
15. Partner A.M., Bhattacharya S., Scott R.A., Stavrou P. Rothia genus endophthalmitis following penetrating injury in a child. Eye (Lond) 2006, 20(4):502-503.
16. Ramanan P., Barreto J.N., Osmon D.R., Tosh P.K. Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota. J Clin Microbiol 2014, 52(9):3184-3189.
17. Shakoor S., Fasih N., Jabeen K., Jamil B. Rothia dentocariosa endocarditis with mitral valve prolapse: case report and brief review. Infection 2011, 39(2):177-179.
18. Tarumoto N., Sujino K., Yamaguchi T., Umeyama T., Ohno H., Miyazaki Y., et al. A first report of Rothia aeria endocarditis complicated by cerebral hemorrhage. Intern Med 2012, 51(23):3295-3299.
19. Thiyagarajan A., Balendra A., Hillier D., Hatcher J. The first report of survival post Rothia aeria endocarditis. BMJ Case Rep 2013, 2013.
20. Trivedi M.N., Malhotra P. Rothia prosthetic knee joint infection. J Microbiol Immunol Infect 2015, 48(4):453-455.
21. Vaccher S., Cordiali R., Osimani P., Manso E., de Benedictis F.M. Bacteremia caused by Rothia mucilaginosa in a patient with Shwachman-Diamond syndrome. Infection 2007, 35(3):209-210.
22. Zinner S.H. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999, 29(3):490-494.